BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15059898)

  • 1. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
    Becker K; Pancoska P; Concin N; Vanden Heuvel K; Slade N; Fischer M; Chalas E; Moll UM
    Int J Oncol; 2006 Oct; 29(4):889-902. PubMed ID: 16964385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.
    Soldevilla B; Díaz R; Silva J; Campos-Martín Y; Muñoz C; García V; García JM; Peña C; Herrera M; Rodriguez M; Gómez I; Mohamed N; Marques MM; Bonilla F; Domínguez G
    Clin Cancer Res; 2011 Sep; 17(18):6029-39. PubMed ID: 21807636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
    Petrenko O; Zaika A; Moll UM
    Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.
    Hofstetter G; Berger A; Chamson M; Müller-Holzner E; Reimer D; Ulmer H; Uramoto H; Marth C; Zeimet AG; Zeillinger R; Concin N
    Int J Gynecol Pathol; 2011 Nov; 30(6):527-31. PubMed ID: 21979586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
    Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
    J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
    Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
    Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
    Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
    Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
    Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
    J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.
    Sayan AE; Roperch JP; Sayan BS; Rossi M; Pinkoski MJ; Knight RA; Willis AE; Melino G
    Ann N Y Acad Sci; 2007 Jan; 1095():315-24. PubMed ID: 17404044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating p73 isoforms in human tumours.
    Coates PJ
    J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
    Hofstetter G; Berger A; Fiegl H; Slade N; Zorić A; Holzer B; Schuster E; Mobus VJ; Reimer D; Daxenbichler G; Marth C; Zeimet AG; Concin N; Zeillinger R
    Oncogene; 2010 Apr; 29(13):1997-2004. PubMed ID: 20101229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.